SARS and COVID-19 are not the same disease, but they are caused by closely related viruses. The virus behind COVID-19 (called SARS-CoV-2) shares about 79% of its genetic sequence with the original SARS virus (SARS-CoV) from 2003. That 21% difference is enough to make them behave very differently in the human body, spread in distinct ways, and produce vastly different outcomes at the population level.
Both belong to the same family of coronaviruses, which is why COVID-19’s full name includes “SARS” in it. But the similarities are roughly like comparing two cousins rather than identical twins. The differences between them explain why one caused a contained outbreak of about 8,000 cases and the other triggered a global pandemic.
How the Two Viruses Are Related
SARS-CoV emerged in southern China in late 2002 and caused an outbreak that lasted until mid-2003. SARS-CoV-2, the virus responsible for COVID-19, was first identified in Wuhan, China, in late 2019. Both viruses likely originated in bats and are classified as betacoronaviruses. They both use the same receptor on human cells to gain entry, which is why they target the lungs and respiratory system.
Despite sharing that 79% genetic identity, the structural differences between the two viruses are significant. SARS-CoV-2 binds more tightly to human cells, which partly explains why it spreads more efficiently. Think of it this way: two vehicles can share most of the same parts but perform very differently if the engine and tires are redesigned.
Why COVID-19 Spread and SARS Didn’t
The single biggest difference between these two diseases is how and when an infected person becomes contagious. With the original SARS, people were most contagious after they already felt sick. That made containment relatively straightforward: identify sick people, isolate them, and trace their contacts. Public health teams could stay ahead of the virus because visible symptoms served as an early warning system.
COVID-19 flipped that equation. A large proportion of people infected with SARS-CoV-2 never develop symptoms at all, or they spread the virus before symptoms appear. Studies have found asymptomatic rates near 60% in some populations. This meant millions of people were unknowingly passing the virus to others in grocery stores, workplaces, and family gatherings, with no fever or cough to tip anyone off. By the time a case was detected, the virus had already moved on to new hosts.
The original SARS outbreak infected roughly 8,098 people across 29 countries over about eight months before it was contained. COVID-19, by contrast, infected hundreds of millions worldwide within its first two years.
Severity and Fatality Rates
Here’s where it gets counterintuitive: SARS was far more deadly on a case-by-case basis, but COVID-19 killed far more people overall. The original SARS had a case fatality rate of about 10%, meaning roughly one in ten people diagnosed with it died. COVID-19’s fatality rate was estimated at around 2% of reported cases early in the pandemic, and likely lower when accounting for undetected mild infections.
That lower fatality rate was, paradoxically, part of what made COVID-19 so dangerous at the global level. Because most people survived (and many felt only mildly ill or nothing at all), the virus could circulate widely without burning itself out. SARS killed or seriously sickened its hosts quickly enough that it couldn’t sustain widespread transmission. COVID-19 found the evolutionary sweet spot: contagious enough to spread explosively, mild enough in most cases to keep its hosts moving around.
The World Health Organization reported 774 deaths from the entire 2003 SARS outbreak. COVID-19 surpassed that number within weeks of becoming a pandemic and ultimately caused millions of deaths worldwide.
Symptoms and Incubation Period
Both diseases can cause fever, cough, shortness of breath, and pneumonia. But COVID-19 has a wider range of symptoms, including loss of taste and smell (especially with earlier variants), fatigue, body aches, and gastrointestinal problems. Some people with COVID-19 develop only a sore throat or mild congestion, while others end up on ventilators. SARS was more consistently severe, with most patients developing noticeable respiratory illness.
The incubation period differs as well. For COVID-19, early studies found an average of about 6.5 days from exposure to symptom onset, though this shortened over time. During waves dominated by the Delta variant, the average dropped to around 4.3 days, and with Omicron it fell further to 3 to 4 days. The original SARS had a typical incubation period of 2 to 7 days, with most cases appearing within 4 to 5 days. In practice, the ranges overlap enough that the two diseases could look similar in their early stages.
One notable difference in COVID-19 is the timing of peak viral load. Virus levels in the respiratory tract tend to peak around the fourth or fifth day of symptoms, which means people can be highly contagious for several days before they feel sick enough to stay home.
Immunity After Infection
Researchers have tracked survivors of the 2003 SARS outbreak for years, and the findings are striking. A study found that 23 individuals who had SARS in 2003 still had immune cells (T-cells) that recognized the virus 17 years later. That’s a remarkably durable immune memory, though with only about 8,000 total cases, there was never a large population to retest.
COVID-19 immunity is more variable. Research using machine learning projections estimated that neutralizing antibodies after COVID-19 infection could last anywhere from 35 days to 41 years, depending on the individual. That enormous range reflects real-world experience: some people caught COVID-19 multiple times within a single year, while others went years without reinfection. Factors like age, severity of the initial infection, and vaccination status all influence how long protection lasts. The virus also mutates faster than the original SARS did, producing new variants that can partially dodge existing immunity.
Why the Names Are So Similar
The naming can cause genuine confusion. “SARS” stands for Severe Acute Respiratory Syndrome, which describes the disease caused by the original 2003 virus. When scientists identified the new coronavirus in 2020, they named it SARS-CoV-2 because of its genetic relationship to the first SARS virus. The disease it causes was given a separate name: COVID-19 (short for Coronavirus Disease 2019).
So technically, “SARS” refers to both the 2003 disease and part of the name of the virus behind COVID-19. In everyday conversation, though, “SARS” almost always means the 2003 outbreak, and “COVID” means the pandemic that began in 2020. They are related but distinct diseases caused by related but distinct viruses, with very different consequences for global health.

